UK markets closed
  • FTSE 100

    7,554.57
    -3.92 (-0.05%)
     
  • FTSE 250

    19,380.65
    -28.77 (-0.15%)
     
  • AIM

    854.63
    +4.07 (+0.48%)
     
  • GBP/EUR

    1.1677
    +0.0034 (+0.29%)
     
  • GBP/USD

    1.2267
    +0.0011 (+0.09%)
     
  • BTC-GBP

    13,799.62
    -104.79 (-0.75%)
     
  • CMC Crypto 200

    401.54
    +0.11 (+0.03%)
     
  • S&P 500

    4,050.95
    -25.62 (-0.63%)
     
  • DOW

    34,258.03
    -136.98 (-0.40%)
     
  • CRUDE OIL

    81.10
    -0.12 (-0.15%)
     
  • GOLD FUTURES

    1,803.10
    -12.10 (-0.67%)
     
  • NIKKEI 225

    27,777.90
    -448.18 (-1.59%)
     
  • HANG SENG

    18,675.35
    -61.09 (-0.33%)
     
  • DAX

    14,514.89
    +24.59 (+0.17%)
     
  • CAC 40

    6,735.19
    -18.78 (-0.28%)
     

Global Upstream Bioprocessing Market to Reach $17 Billion by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Upstream Bioprocessing estimated at US$7 Billion in the year 2020, is projected to reach a revised size of US$17 Billion by 2027, growing at a CAGR of 13.

New York, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Upstream Bioprocessing Industry" - https://www.reportlinker.com/p06033199/?utm_source=GNW
4% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 13.7% CAGR and reach US$8.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Media Preparation segment is readjusted to a revised 12.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 12.9% CAGR

The Upstream Bioprocessing market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3 Billion by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 11.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Cell Separation Segment to Record 14.1% CAGR

In the global Cell Separation segment, USA, Canada, Japan, China and Europe will drive the 14.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 34 Featured) -
AGC Biologics
Applikon Biotechnology
Biotech Labs Pvt. Ltd.
Boehringer Ingelheim International GmbH
CellGenix GmbH
Corning, Inc.
Danaher
Eppendorf AG
GE Healthcare
Lonza Group AG
Merck KGaA
Patheon N.V
PBS Biotech, Inc.
Samsung Biologics
Sartorius AG
Thermo Fisher Scientific, Inc.


Read the full report: https://www.reportlinker.com/p06033199/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Upstream Bioprocessing - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Upstream Bioprocessing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Upstream Bioprocessing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for Cell
Culture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Cell Culture by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Cell Culture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for Media
Preparation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Media Preparation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Media Preparation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for Cell
Separation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Cell Separation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Cell Separation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 13: World Upstream Bioprocessing Market Analysis of
Annual Sales in US$ Million for Years 2012 through 2027

Table 14: World Recent Past, Current & Future Analysis for
Multi by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 15: World Historic Review for Multi by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 16: World 15-Year Perspective for Multi by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027

Table 17: World Recent Past, Current & Future Analysis for
Single by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 18: World Historic Review for Single by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 19: World 15-Year Perspective for Single by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 20: USA Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 21: USA Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 22: USA 15-Year Perspective for Upstream Bioprocessing by
Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 23: USA Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 24: USA Historic Review for Upstream Bioprocessing by Use
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 25: USA 15-Year Perspective for Upstream Bioprocessing by
Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

CANADA
Table 26: Canada Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 27: Canada Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 28: Canada 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 29: Canada Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 30: Canada Historic Review for Upstream Bioprocessing by
Use Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 31: Canada 15-Year Perspective for Upstream Bioprocessing
by Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

JAPAN
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 32: Japan Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 33: Japan Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 34: Japan 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 35: Japan Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 36: Japan Historic Review for Upstream Bioprocessing by
Use Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 37: Japan 15-Year Perspective for Upstream Bioprocessing
by Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

CHINA
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 38: China Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 39: China Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 40: China 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 41: China Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 42: China Historic Review for Upstream Bioprocessing by
Use Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 43: China 15-Year Perspective for Upstream Bioprocessing
by Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

EUROPE
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 44: Europe Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 45: Europe Historic Review for Upstream Bioprocessing by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 46: Europe 15-Year Perspective for Upstream Bioprocessing
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2021 & 2027

Table 47: Europe Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 48: Europe Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 49: Europe 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 50: Europe Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 51: Europe Historic Review for Upstream Bioprocessing by
Use Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 52: Europe 15-Year Perspective for Upstream Bioprocessing
by Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

FRANCE
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 53: France Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 54: France Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 55: France 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 56: France Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 57: France Historic Review for Upstream Bioprocessing by
Use Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 58: France 15-Year Perspective for Upstream Bioprocessing
by Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

GERMANY
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 59: Germany Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 60: Germany Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 61: Germany 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2021 & 2027

Table 62: Germany Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 63: Germany Historic Review for Upstream Bioprocessing by
Use Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 64: Germany 15-Year Perspective for Upstream
Bioprocessing by Use Type - Percentage Breakdown of Value Sales
for Multi and Single for the Years 2012, 2021 & 2027

ITALY
Table 65: Italy Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 66: Italy Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 67: Italy 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 68: Italy Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 69: Italy Historic Review for Upstream Bioprocessing by
Use Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 70: Italy 15-Year Perspective for Upstream Bioprocessing
by Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

UNITED KINGDOM
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 71: UK Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 72: UK Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 73: UK 15-Year Perspective for Upstream Bioprocessing by
Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2021 & 2027

Table 74: UK Recent Past, Current & Future Analysis for
Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 75: UK Historic Review for Upstream Bioprocessing by Use
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 76: UK 15-Year Perspective for Upstream Bioprocessing by
Use Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2021 & 2027

REST OF EUROPE
Table 77: Rest of Europe Recent Past, Current & Future Analysis
for Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 78: Rest of Europe Historic Review for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 79: Rest of Europe 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2021 & 2027

Table 80: Rest of Europe Recent Past, Current & Future Analysis
for Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 81: Rest of Europe Historic Review for Upstream
Bioprocessing by Use Type - Multi and Single Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 82: Rest of Europe 15-Year Perspective for Upstream
Bioprocessing by Use Type - Percentage Breakdown of Value Sales
for Multi and Single for the Years 2012, 2021 & 2027

ASIA-PACIFIC
Upstream Bioprocessing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 83: Asia-Pacific Recent Past, Current & Future Analysis
for Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 84: Asia-Pacific Historic Review for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 85: Asia-Pacific 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2021 & 2027

Table 86: Asia-Pacific Recent Past, Current & Future Analysis
for Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 87: Asia-Pacific Historic Review for Upstream
Bioprocessing by Use Type - Multi and Single Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 88: Asia-Pacific 15-Year Perspective for Upstream
Bioprocessing by Use Type - Percentage Breakdown of Value Sales
for Multi and Single for the Years 2012, 2021 & 2027

REST OF WORLD
Table 89: Rest of World Recent Past, Current & Future Analysis
for Upstream Bioprocessing by Workflow - Cell Culture, Media
Preparation and Cell Separation - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 90: Rest of World Historic Review for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 91: Rest of World 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2021 & 2027

Table 92: Rest of World Recent Past, Current & Future Analysis
for Upstream Bioprocessing by Use Type - Multi and Single -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 93: Rest of World Historic Review for Upstream
Bioprocessing by Use Type - Multi and Single Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 94: Rest of World 15-Year Perspective for Upstream
Bioprocessing by Use Type - Percentage Breakdown of Value Sales
for Multi and Single for the Years 2012, 2021 & 2027

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06033199/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001